The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.
The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion is about 43%.
USA is the largest market, with a sales market share nearly 65%. Following USA, Europe is the second largest market with the sales market share of 30%.
Market competition will intense. AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.
The global Humira market was valued at US$ 17920 million in 2020 and is expected to reach US$ 10150 million by the end of 2027, growing at a CAGR of -8.3% during 2021-2027.
This report focuses on Humira volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Humira market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Humira Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Humira Syringe
Humira Pen
Segment by Application
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
AbbVie
Eisai
Cadila Healthcare
Torrent Pharmaceuticals
Amgen
Boehringer Ingelheim
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.
The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion is about 43%.
USA is the largest market, with a sales market share nearly 65%. Following USA, Europe is the second largest market with the sales market share of 30%.
Market competition will intense. AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.
The global Humira market was valued at US$ 17920 million in 2020 and is expected to reach US$ 10150 million by the end of 2027, growing at a CAGR of -8.3% during 2021-2027.
This report focuses on Humira volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Humira market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Humira Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Humira Syringe
Humira Pen
Segment by Application
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
AbbVie
Eisai
Cadila Healthcare
Torrent Pharmaceuticals
Amgen
Boehringer Ingelheim
Index1 Humira Market Overview
1.1 Product Overview and Scope of Humira
1.2 Humira Segment by Type
1.2.1 Global Humira Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Humira Syringe
1.2.3 Humira Pen
1.3 Humira Segment by Application
1.3.1 Global Humira Sales Comparison by Application: (2021-2027)
1.3.2 Ankylosing Spondylitis
1.3.3 Rheumatoid Arthritis
1.3.4 Crohn’s Disease
1.3.5 Others
1.4 Global Humira Market Size Estimates and Forecasts
1.4.1 Global Humira Revenue 2016-2027
1.4.2 Global Humira Sales 2016-2027
1.4.3 Humira Market Size by Region: 2016 Versus 2021 Versus 2027
2 Humira Market Competition by Manufacturers
2.1 Global Humira Sales Market Share by Manufacturers (2016-2021)
2.2 Global Humira Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Humira Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Humira Manufacturing Sites, Area Served, Product Type
2.5 Humira Market Competitive Situation and Trends
2.5.1 Humira Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Humira Players Market Share by Revenue
2.5.3 Global Humira Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Humira Retrospective Market Scenario by Region
3.1 Global Humira Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Humira Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Humira Market Facts & Figures by Country
3.3.1 North America Humira Sales by Country
3.3.2 North America Humira Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Humira Market Facts & Figures by Country
3.4.1 Europe Humira Sales by Country
3.4.2 Europe Humira Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Humira Market Facts & Figures by Region
3.5.1 Asia Pacific Humira Sales by Region
3.5.2 Asia Pacific Humira Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Humira Market Facts & Figures by Country
3.6.1 Latin America Humira Sales by Country
3.6.2 Latin America Humira Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Humira Market Facts & Figures by Country
3.7.1 Middle East and Africa Humira Sales by Country
3.7.2 Middle East and Africa Humira Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Humira Historic Market Analysis by Type
4.1 Global Humira Sales Market Share by Type (2016-2021)
4.2 Global Humira Revenue Market Share by Type (2016-2021)
4.3 Global Humira Price by Type (2016-2021)
5 Global Humira Historic Market Analysis by Application
5.1 Global Humira Sales Market Share by Application (2016-2021)
5.2 Global Humira Revenue Market Share by Application (2016-2021)
5.3 Global Humira Price by Application (2016-2021)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Corporation Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Humira Sales, Revenue and Gross Margin (2016-2021)
6.1.4 AbbVie Humira Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Eisai
6.2.1 Eisai Corporation Information
6.2.2 Eisai Description and Business Overview
6.2.3 Eisai Humira Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Eisai Humira Product Portfolio
6.2.5 Eisai Recent Developments/Updates
6.3 Cadila Healthcare
6.3.1 Cadila Healthcare Corporation Information
6.3.2 Cadila Healthcare Description and Business Overview
6.3.3 Cadila Healthcare Humira Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Cadila Healthcare Humira Product Portfolio
6.3.5 Cadila Healthcare Recent Developments/Updates
6.4 Torrent Pharmaceuticals
6.4.1 Torrent Pharmaceuticals Corporation Information
6.4.2 Torrent Pharmaceuticals Description and Business Overview
6.4.3 Torrent Pharmaceuticals Humira Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Torrent Pharmaceuticals Humira Product Portfolio
6.4.5 Torrent Pharmaceuticals Recent Developments/Updates
6.5 Amgen
6.5.1 Amgen Corporation Information
6.5.2 Amgen Description and Business Overview
6.5.3 Amgen Humira Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Amgen Humira Product Portfolio
6.5.5 Amgen Recent Developments/Updates
6.6 Boehringer Ingelheim
6.6.1 Boehringer Ingelheim Corporation Information
6.6.2 Boehringer Ingelheim Description and Business Overview
6.6.3 Boehringer Ingelheim Humira Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Boehringer Ingelheim Humira Product Portfolio
6.6.5 Boehringer Ingelheim Recent Developments/Updates
7 Humira Manufacturing Cost Analysis
7.1 Humira Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Humira
7.4 Humira Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Humira Distributors List
8.3 Humira Customers
9 Humira Market Dynamics
9.1 Humira Industry Trends
9.2 Humira Growth Drivers
9.3 Humira Market Challenges
9.4 Humira Market Restraints
10 Global Market Forecast
10.1 Humira Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Humira by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Humira by Type (2022-2027)
10.2 Humira Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Humira by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Humira by Application (2022-2027)
10.3 Humira Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Humira by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Humira by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Humira Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Humira Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Humira Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Humira Covered in This Study
Table 5. Global Humira Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Humira Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Humira Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Humira Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Humira Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Humira Manufacturing Sites and Area Served
Table 11. Manufacturers Humira Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Humira by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Humira as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Humira Sales by Region (2016-2021) & (K Units)
Table 16. Global Humira Sales Market Share by Region (2016-2021)
Table 17. Global Humira Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Humira Sales by Country (2016-2021) & (K Units)
Table 19. North America Humira Sales Market Share by Country (2016-2021)
Table 20. North America Humira Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Humira Revenue Market Share by Country (2016-2021)
Table 22. Europe Humira Sales by Country (2016-2021) & (K Units)
Table 23. Europe Humira Sales Market Share by Country (2016-2021)
Table 24. Europe Humira Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Humira Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Humira Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Humira Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Humira Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Humira Revenue Market Share by Region (2016-2021)
Table 30. Latin America Humira Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Humira Sales Market Share by Country (2016-2021)
Table 32. Latin America Humira Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Humira Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Humira Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Humira Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Humira Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Humira Revenue Market Share by Country (2016-2021)
Table 38. Global Humira Sales (K Units) by Type (2016-2021)
Table 39. Global Humira Sales Market Share by Type (2016-2021)
Table 40. Global Humira Revenue (Million US$) by Type (2016-2021)
Table 41. Global Humira Revenue Share by Type (2016-2021)
Table 42. Global Humira Price (USD/Unit) by Type (2016-2021)
Table 43. Global Humira Sales (K Units) by Application (2016-2021)
Table 44. Global Humira Sales Market Share by Application (2016-2021)
Table 45. Global Humira Revenue (Million US$) by Application (2016-2021)
Table 46. Global Humira Revenue Share by Application (2016-2021)
Table 47. Global Humira Price (USD/Unit) by Application (2016-2021)
Table 48. AbbVie Corporation Information
Table 49. AbbVie Description and Business Overview
Table 50. AbbVie Humira Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. AbbVie Humira Product
Table 52. AbbVie Recent Developments/Updates
Table 53. Eisai Corporation Information
Table 54. Eisai Description and Business Overview
Table 55. Eisai Humira Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Eisai Humira Product
Table 57. Eisai Recent Developments/Updates
Table 58. Cadila Healthcare Corporation Information
Table 59. Cadila Healthcare Description and Business Overview
Table 60. Cadila Healthcare Humira Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Cadila Healthcare Humira Product
Table 62. Cadila Healthcare Recent Developments/Updates
Table 63. Torrent Pharmaceuticals Corporation Information
Table 64. Torrent Pharmaceuticals Description and Business Overview
Table 65. Torrent Pharmaceuticals Humira Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Torrent Pharmaceuticals Humira Product
Table 67. Torrent Pharmaceuticals Recent Developments/Updates
Table 68. Amgen Corporation Information
Table 69. Amgen Description and Business Overview
Table 70. Amgen Humira Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Amgen Humira Product
Table 72. Amgen Recent Developments/Updates
Table 73. Boehringer Ingelheim Corporation Information
Table 74. Boehringer Ingelheim Description and Business Overview
Table 75. Boehringer Ingelheim Humira Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Boehringer Ingelheim Humira Product
Table 77. Boehringer Ingelheim Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Humira Distributors List
Table 81. Humira Customers List
Table 82. Humira Market Trends
Table 83. Humira Growth Drivers
Table 84. Humira Market Challenges
Table 85. Humira Market Restraints
Table 86. Global Humira Sales Forecast by Type (2022-2027) & (K Units)
Table 87. Global Humira Sales Market Share Forecast by Type (2022-2027)
Table 88. Global Humira Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 89. Global Humira Revenue Market Share Forecast by Type (2022-2027)
Table 90. Global Humira Sales Forecast by Application (2022-2027) & (K Units)
Table 91. Global Humira Sales Market Share Forecast by Application (2022-2027)
Table 92. Global Humira Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 93. Global Humira Revenue Market Share Forecast by Application (2022-2027)
Table 94. Global Humira Sales Forecast by Region (2022-2027) & (K Units)
Table 95. Global Humira Sales Market Share Forecast by Region (2022-2027)
Table 96. Global Humira Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 97. Global Humira Revenue Market Share Forecast by Region (2022-2027)
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Humira
Figure 2. Global Humira Market Share by Type in 2020 & 2027
Figure 3. Humira Syringe Product Picture
Figure 4. Humira Pen Product Picture
Figure 5. Global Humira Market Share by Application in 2020 & 2027
Figure 6. Ankylosing Spondylitis
Figure 7. Rheumatoid Arthritis
Figure 8. Crohn’s Disease
Figure 9. Others
Figure 10. Global Humira Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Humira Market Size 2016-2027 (US$ Million)
Figure 12. Global Humira Sales 2016-2027 (K Units)
Figure 13. Global Humira Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Humira Sales Share by Manufacturers in 2020
Figure 15. Global Humira Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Humira Players: Market Share by Revenue in 2020
Figure 17. Humira Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Humira Sales Market Share by Region (2016-2021)
Figure 19. Global Humira Sales Market Share by Region in 2020
Figure 20. Global Humira Revenue Market Share by Region (2016-2021)
Figure 21. Global Humira Revenue Market Share by Region in 2020
Figure 22. U.S. Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. China Taiwan Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Humira Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Humira by Type (2016-2021)
Figure 45. Sales Market Share of Humira by Application (2016-2021)
Figure 46. Sales Market Share of Humira by Application in 2020
Figure 47. Revenue Share of Humira by Application (2016-2021)
Figure 48. Revenue Share of Humira by Application in 2020
Figure 49. Manufacturing Cost Structure of Humira
Figure 50. Manufacturing Process Analysis of Humira
Figure 51. Humira Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
